Back

Prevalence of undiagnosed pre-diabetes or diabetes in patients with HFpEF presenting in the emergency department.

13 March 2021 (08:30 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Clinical ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Maria Stratinaki

Venizelio General Hospital, Heraklion (Greece)

153 More presentations in this session

Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Portugal
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Belgium
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
The clinical significance of blood lactate levels in evaluation of adult patients with Veno-Arterial Extracorporeal Membrane Oxygenation .
Assistant Professor M. Laimoud (Riyadh, SA)
Abstract
Presentation thumbnail
Implantable loop recorder: experience of a center
Doctor C. Marques Pires (Braga, PT)
Abstract
Presentation thumbnail
Bleeding predictors in acute coronary syndrome: does the age or clinical presentation matters?
Doctor C. Marques Pires (Braga, PT)
Abstract

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

ACVC 2021

13 March 2021 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of undiagnosed prediabetes or type 2 diabetes mellitus in patients admitted with heart failure.
29 June 2021
thumbnail
Congress Presentation
Diagnosing heart failure with preserved ejection fraction in patients with unexplained dyspnea using exercise echocardiography: impact of different diagnostic thresholds
21 May 2023
thumbnail
Congress Presentation
The prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
22 May 2023
thumbnail
Congress Presentation
Use of Intravenous ferric carboximaltose in heart failure with preserved or intermediate ejection fraction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources